SlideShare une entreprise Scribd logo
1  sur  35
Presenting the ACCJ-EBC
Health Policy White Paper 2013
May 31, 2013
Lengthening Healthy Lifespans
to Boost Economic Growth
Laurence W. Bates
ACCJ President
About American Chamber of Commerce in
Japan
Established
1948
Committee structure drives Chamber
activities around three pillars:
• Information
• Networking
• Advocacy
Approximately
2700 members
representing
1000 companies
Over 500 events
per year in three
chapters across
Japan
Approximately
half of members
are Japanese
Achieving Growth Together
Japan Economic
Growth
ACCJ Membership
Growth
ACCJ Member
Personal Growth
ACCJ’s Three Primary Areas for Growth
成 長 共 就
Preventive Health Investment Drives Growth
Japan’s aging is rapidly increasing healthcare utilization
Worker productivity is key to sustain healthcare and grow
the economy
• Disease costs Japanese economy 3.3 trillion yen per year in lost
productivity (2011 ACCJ National Survey)
A shift to prevention and early detection is necessary to:
 Increase healthy life years
 Lower economic burden of disease
 Support economic growth
• Gaps between average life expectancy and healthy life expectancy
represent an unhealthy period with daily life constraints
• There may be medical and nursing expenses during this period
70.42
79.64
60
73.62
86.39
65 70 75 80 85 90
Year
9.22 years
12.77 years
Average life expectancy Healthy life expectancy (No daily life constraints)
Gap between average and healthy life expectancy
Male
Female
Source: Healthy Japan 21 (Second Version)
Importance of Healthier Life Expectancy
ACCJ-EBC Health Policy White Paper 2013
Promoting economic growth in Japan
through policies to lengthen healthy
lifespans and
reduce economic burden of preventable,
detectable and treatable diseases
36 healthcare topics
Over 150 policy
recommendations
Duco B. Delgorge
EBC Chairman
About European Business Council in Japan
Trade policy arm
of 17 European
National
Chambers of
Commerce and
Business
Associations in
Japan
Working to improve the trade and
investment environment for European
companies in Japan since
1972
Approximately 3000 local European
corporate and individual members
Approximately
400 companies
participating
directly
Rise in Non-Communicable Diseases Is a
Leading Threat to Global Economic Growth
WHO report: each 10% rise in non-
communicable diseases is linked to a
0.5% dip in annual economic growth;
recent global rise in NCDs is
“economically unsustainable.”
The World Economic Forum forecasts
that NCDs will cost the global economy
$47 trillion over the next 20 years.
• Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.”
Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010,” WHO,
http://www.who.int/nmh/publications/ncd_report2010/en/
• Working Towards Wellness: The Business Rationale. World Economic Forum, Geneva, 2008. Bloom, et al., 2011.
NCDs account for about 30% of national healthcare expenditure and
about 60% of total deaths
Healthcare Expenditure
Cancers 11.1%
Hypertension-related
diseases 7.1%
Cerebral vascular
diseases 6.3%
Diabetes 4.4%
Cardiovascular
diseases 2.9%
Others
68.3%
Cancers
29.5%
Cardiovascular
diseases 15.8%
Cerebral vascular
diseases 10.3%
Diabetes 1.2%
Hypertension-related
diseases 0.6%
Others
42.6%
Mortality
Source: Healthy Japan 21 (Part 2)
Non-Communicable Diseases in Japan are
Costly, Deadly and Often Preventable
“Every 1 year increase in life
expectancy is linked to a 4.3%
increase in global GDP.”
Sources: Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.”
Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010, WHO,
http://www.who.int/nmh/publications/ncd_report2010/en/.
Spending to Promote Health is a Very Good
Economic Investment
William Bishop
Chair, ACCJ Healthcare Committee
2010
2010 Health Policy White Paper
2010
2011 Health Policy White Paper
2011
Scope:
• 27 Topic Sections
• 124 Recommendations
Results:
• 46 of 124 recommendations (roughly 37%)
fulfilled “in part" or in whole
Areas of Progress:
• Continued government funding of national
cancer screening
• Substantial increased funding to enhance
infection prevention and control at hospitals
in Japan (four fold for hospitals with >300
beds).
• Expanded use of IVD Rapid Diagnostics
• Diabetes Management
• Osteoporosis Prevention
• Chronic Pain Research Funding
• Vaccination Policy
• Hepatitis Screening & Awareness Initiatives
Source: Inhibitex
Nearly 6 million HAIs
annually in U.S., Europe and
Japan
1.7 million cases and 99,000
deaths annually in the U.S.
In some developing countries,
more than 25% of patients
admitted to hospitals acquire
HAIs
Hundreds of millions of
patients impacted worldwide
each year
Healthcare Associated Infections (HAIs):
A Global Healthcare Issue
Millions of Infections
8
6
4
2
0
2002 2005 2009 2010 2015
5.6 5.9
6.3 6.4
6.9
Japan
Europe
U.S.
Q. How important do you think it is for the government to have a national
program to reduce the risk of infections associated with hospitals, clinics
or other healthcare facilities?
75.7% of General Public in Japan Think it is
Important to Have a National Program to Reduce
the Risk of HAIs (80% for population over 65)
■ Important ■ Slightly important ■ Neither nor ■ Do not know ■ Not very important ■ Not important
52.4
48.9
48.5
43.0
37.3
31.4
29.4
40.8
40.2
40.5
27.4
30.6
32.9
36.2
36.4
39.2
38.1
35.9
34.4
35.2
7.7
12.9
11.2
12.1
15.9
17.6
18.6
14.4
14.2
14.3
10.6
5.6
5.6
5.9
7.4
7.9
7.4
6.3
7.2
6.8
1.9
1.4
1.2
2.1
1.8
2.5
6.6
2.0
2.2
2.1
0% 20% 40% 60% 80% 100%
80+ yrs old (n=208)
70-79 yrs old (n=790)
60-69 yrs old (n=882)
50-59 yrs old (n=779)
40-49 yrs old (n=800)
30-39 yrs old (n=863)
20-29 yrs old (n=678)
Female (n=2599)
Male (n=2401)
Overall (n=5000)
Is Important
75.7%
74.6%
76.6%
67.4%
70.6%
73.6%
79.2%
81.4%
79.5%
79.8%
Not Important
3.3%
3.9%
2.6%
6.6%
3.9%
3.2%
2.9%
1.8%
2.0%
1.9%
Survey on Prevention, Early Detection and the Economic Burden of Disease in Japan (2011) by The American Chamber of Commerce in
Japan. Internet survey conducted October 31 – November 2, 2011. 5,000 respondents from Rakuten Research’s registry that represent
the Japanese population.
2013
2013 ACCJ-EBC Health Policy White Paper
Scope:
• 36 Topic Sections
• 156 Recommendations
Chapters:
1. General Health Themes
2. Non-communicable Disease
(NCD) Topics
3. Women’s Health Topics
4. Key Infectious Disease Topics
5. Importance of Enhanced Safety
& Infection Control
6. Special Focus Needed on
Healthcare Worker Safety
Danny Risberg
Chair, EBC Medical Equipment Committee
Deaths Caused by and Patients of
Cerebrovascular Diseases
100
125
150
175
200
0
250
500
750
1,000
1,250
1,500
1,750
2,000
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
# of death
(1,000 ppl)
# of Patients
(1,000 ppl)
# of
Patients
# of
Death
Source: Ministry of Health, Labor, and Welfare (Trend of Medical Institution)
76.8%
13.3%
2.4% 7.5%
Cerebral hemorrhage
Cerebral infarction
Subarachnoid hemorrhage
Others
1960
1999
Source: Ministry of Health, Labor, and Welfare (Vital Statistics)
Deaths Caused By Cerebrovascular
Diseases
23.0%
62.7%
10.8% 3.5%
Vessel Wall Imaging Done by MRI
Sleep Apnea Syndrome
(over 3 million patients)
13% have diabetes
(390,000 patients)
21% have cardiovascular diseases
(630,000 patients)
41% no complication
(1,230,000 patients)
51% have hypertension
(1,530,000 patients)
Undergoing
Treatment
(250,000 patients)
Increase Sleep Apnea Syndrome Screening
Eriko Asai
Chair, ACCJ Health IT Subcommittee
71.5% of Japanese Back Introduction of Electronic
Health Records at Hospitals, Clinics
Support/Agree Slightly Support/Agree Neither
Don’t know Slightly Oppose/Disagree Oppose/Disagree
50.0
48.2
52.4
42.2
40.3
35.9
36.1
37.9
48.7
43.1
23.6
28.0
24.3
28.4
28.3
33.4
29.8
31.6
25.0
28.4
14.4
16.1
17.1
22.2
22.8
20.4
20.8
21.8
17.2
19.6
10.1
5.1
4.4
5.4
5.9
6.6
8.3
5.9
6.2
6.0
0.5
1.9
1.5
1.2
2.3
2.5
2.9
2.2
1.7
2.0
0% 20% 40% 60% 80% 100%
80+ yrs old (n=208)
70-79 yrs old (n=790)
60-69 yrs old (n=882)
50-59 yrs old (n=779)
40-49 yrs old (n=800)
30-39 yrs old (n=863)
20-29 yrs old (n=678)
Female (n=2599)
Male (n=2401)
Overall (n=5000) 71.5%
73.7%
69.4%
65.9%
69.3%
68.5%
70.6%
76.6%
76.2%
73.6%
Support Oppose
2.9%
2.9%
2.9%
5.0%
3.7%
2.9%
1.8%
1.8%
2.7%
1.9%
Q: Do you support or oppose the introduction of electronic health records at
hospitals and clinics in Japan?
Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov, 2011.
Supporters of EHR System Expect
More Efficiency, Safer Medical Service
(n=3,574)
Q: Why do you support the introduction of an electronic health record (EHR) system
at hospitals and clinics in Japan? (multiple answers)
Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov. 2011.
24.3%
70% 75%
Breast Cancer Screening Rates Lower Than
OECD Average
Sources:
http://www.mhlw.go.jp/stf/houdou/2r9852000001igt0.html, http://www.oecdto
Mammography
screening rates
in Japan rising,
but still low
62.2%
Free National Breast Cancer Screening
Launched in 2009
Scope: Women aged 40, 45, 50, 55, and 60
Funding: 100% by central government
Japan Goal: 50% screening rate by 2011
Recruitment: Send coupons to eligible women
 Has a 28% survival
rate over five years
 Costs up to ¥4
million to treat
 Has 96% survival
rate over five
years
 Costs about
¥760,000 to treat
Breast cancer diagnosed
in early stages
Breast cancer diagnosed
after it has metastasized
Breast Cancer Screening:
Cost Effective and Saves Lives
 Sense no need, as have no
lump
 Lack of opportunity
 High fees
Top three reasons
women do not have
a mammogram
Bruce Ellsworth
ACCJ Governor
Healthcare Committee Liaison
Two Thirds Support a Mandated Indoor
Worksite Smoking Ban
Question: What would you think if the national or local governments legally required
a complete smoking ban in all indoor workplaces and public spaces, including
restaurants, bars and taxis, to protect the health of non-smoking workers?
Source: Japan national survey on passive smoking in the workplace for 8,000 indoor workers by Johnson &
Johnson K.K. Consumer Company, released on July 19th, 2012
70% of Indoor Workers: Legal Smoking Ban
Would Not Negatively Impact Business
Question: How would your business be impacted if national or local governments
legally required a total smoking ban in all indoor workplaces and public
spaces, including restaurants, bars and taxis, to protect the health of non-smoking
workers?
Source: Japan national survey on passive smoking in the workplace of 8,000 indoor workers by Johnson & Johnson K.K. Consumer Company, July 2012
322011 MHLW’ National Survey on Getting-tested status of Hepatitis Screening (Interviewed 74,000 Japanese people aged 20 thru 79 years old)
Only Half of Adults in Japan Have Been
Screened for Hepatitis
Japanese government has provided free hepatitis screening since 2002 as the
time of regular health checkup services by municipal governments. Free
screening was first provided at public health centers and later also available at
hospitals and clinics.
Need to further increase screening rate, especially for people aged 40 and over.
HCV Screening Rate: Est. 48%HCB Screening Rate: Est. 57%
Tested at time
of
surgery, pregn
ancy, blood
donation 40%
No, I have
not or do
not know
42%
Yes, I have
been tested
(self-
reported)
18%
Yes, I have
been tested
(self-
reported)
18%
No, I have
not or do
not know
52%
Tested at time
of
surgery, pregn
ancy, blood
donation 30%
Large Company
Employers
Small and Medium
Company Employers
Self-Employed and
Others
Type of health
insurance in which
employee enrolls
Managed by health
insurance societies or
associations
Managed by members
of Japan Health
Insurance Association
Managed by
municipalities, National
Health Insurance
associations
Provision of health
checkups based on
Industrial Safety &
Health Act
Yes, required
(Employers are required to provide)
Not required
Provision of special
health checkups based
on Law for the Welfare
of the Elderly (aged 40
or over)
Yes, provision is required
(Insurance provider is required to provide)
Rate at which hepatitis
screening is part of
special health checkup
Approx. 50% Approx. 95%
Individuals must pay ¥595
as co-payment and apply
separately for this optional
hepatitis virus testing.
Approx. 80%
Free but implementation
varies by town, city.
Screening notices usually
go to specific age groups.
Source: MHLW, “Status of implementation of Specific Medical Checkups/Health Guidance in FY2010”
http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info03_h22.html
Provision of Hepatitis Screening Varies
Widely According to Type of Insurer
2013 ACCJ-EBC Health Policy White Paper
• Paradigm shift from treatment to prevention
 Focusing on prevention, screening, early detection and early treatment of
disease
• Efficient allocation of healthcare resources
 Enhancing productivity and reducing waste
• Evidence-based global best practices
 Recommendations with potential to yield significant positive impact
• Alignment with government growth policy goals
 Recommendations with potential to boost economic growth
Disease prevention • Cost effective interventions
• Better patient outcomes and quality of life •
Enhanced labor productivity
Presenting the ACCJ-EBC
Health Policy White Paper 2013
May 31, 2013
Lengthening Healthy Lifespans
to Boost Economic Growth

Contenu connexe

Tendances

Health care system of japan
Health care system of japanHealth care system of japan
Health care system of japanAmina Khan
 
Wrap-up: Creating & Managing New Models of Care in Thailand
Wrap-up: Creating & Managing New Models of Care in ThailandWrap-up: Creating & Managing New Models of Care in Thailand
Wrap-up: Creating & Managing New Models of Care in ThailandBorwornsom Leerapan
 
korean healthcare system overview
korean healthcare system overviewkorean healthcare system overview
korean healthcare system overviewChiweon Kim
 
Go-to-Market Strategy: Launching a Diabetes Treatment in China
Go-to-Market Strategy: Launching a Diabetes Treatment in ChinaGo-to-Market Strategy: Launching a Diabetes Treatment in China
Go-to-Market Strategy: Launching a Diabetes Treatment in ChinaKristy Burton
 
Healthcare system in taiwan
Healthcare system in taiwanHealthcare system in taiwan
Healthcare system in taiwan翰泓 李
 
Masahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanMasahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanNuffield Trust
 
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...Health IT Conference – iHT2
 
Health Economics and Health Finance :Jordan Health Policy Directions
Health Economics  and Health Finance  :Jordan Health Policy Directions   Health Economics  and Health Finance  :Jordan Health Policy Directions
Health Economics and Health Finance :Jordan Health Policy Directions Musa Ajlouni
 

Tendances (20)

Health care system of japan
Health care system of japanHealth care system of japan
Health care system of japan
 
Linking Systems to Strategy - Key Challenges
Linking Systems to Strategy - Key ChallengesLinking Systems to Strategy - Key Challenges
Linking Systems to Strategy - Key Challenges
 
APO Japan Health System Review (Health in Transition)
APO Japan Health System Review (Health in Transition)APO Japan Health System Review (Health in Transition)
APO Japan Health System Review (Health in Transition)
 
Wrap-up: Creating & Managing New Models of Care in Thailand
Wrap-up: Creating & Managing New Models of Care in ThailandWrap-up: Creating & Managing New Models of Care in Thailand
Wrap-up: Creating & Managing New Models of Care in Thailand
 
APO People's Republic of China Health System Review (Health in Transition)
APO People's Republic of China Health System Review (Health in Transition)APO People's Republic of China Health System Review (Health in Transition)
APO People's Republic of China Health System Review (Health in Transition)
 
Solomon Islands health system review
Solomon Islands health system reviewSolomon Islands health system review
Solomon Islands health system review
 
Rapid assessment revised
Rapid assessment   revised Rapid assessment   revised
Rapid assessment revised
 
APO Cambodia Health System Review (Health in Transition)
APO Cambodia Health System Review (Health in Transition)APO Cambodia Health System Review (Health in Transition)
APO Cambodia Health System Review (Health in Transition)
 
korean healthcare system overview
korean healthcare system overviewkorean healthcare system overview
korean healthcare system overview
 
Go-to-Market Strategy: Launching a Diabetes Treatment in China
Go-to-Market Strategy: Launching a Diabetes Treatment in ChinaGo-to-Market Strategy: Launching a Diabetes Treatment in China
Go-to-Market Strategy: Launching a Diabetes Treatment in China
 
High Performing Crowds in Healthcare
High Performing Crowds in HealthcareHigh Performing Crowds in Healthcare
High Performing Crowds in Healthcare
 
Healthcare system in taiwan
Healthcare system in taiwanHealthcare system in taiwan
Healthcare system in taiwan
 
Masahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in JapanMasahiko Hayashi: Long-term care insurance in Japan
Masahiko Hayashi: Long-term care insurance in Japan
 
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...
Health IT Summit Austin 2013 - Keynote Presentation "The Innovation, Data & H...
 
APO policy brief: Use of CHWs to manage and prevent NCDs: policy options base...
APO policy brief: Use of CHWs to manage and prevent NCDs: policy options base...APO policy brief: Use of CHWs to manage and prevent NCDs: policy options base...
APO policy brief: Use of CHWs to manage and prevent NCDs: policy options base...
 
APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)
 
The Road to eHealth: Thailand's Journey
The Road to eHealth: Thailand's JourneyThe Road to eHealth: Thailand's Journey
The Road to eHealth: Thailand's Journey
 
APO The Kingdom of Bhutan Health System Review (Health in Transition)
APO The Kingdom of Bhutan Health System Review (Health in Transition)APO The Kingdom of Bhutan Health System Review (Health in Transition)
APO The Kingdom of Bhutan Health System Review (Health in Transition)
 
MD5AssgnKoulagnaR.
MD5AssgnKoulagnaR.MD5AssgnKoulagnaR.
MD5AssgnKoulagnaR.
 
Health Economics and Health Finance :Jordan Health Policy Directions
Health Economics  and Health Finance  :Jordan Health Policy Directions   Health Economics  and Health Finance  :Jordan Health Policy Directions
Health Economics and Health Finance :Jordan Health Policy Directions
 

En vedette

Android Design Pattern-CH Part ii
Android Design Pattern-CH Part iiAndroid Design Pattern-CH Part ii
Android Design Pattern-CH Part iiGinger Yu
 
Android design pattern
Android design patternAndroid design pattern
Android design patternGinger Yu
 
Othello background power point notes sheet
Othello background power point notes sheetOthello background power point notes sheet
Othello background power point notes sheetjassch
 
Android Design Pattern-CH Part iii
Android Design Pattern-CH Part iiiAndroid Design Pattern-CH Part iii
Android Design Pattern-CH Part iiiGinger Yu
 
20140712 働く場所はここから efsumi2014_donmaico
20140712 働く場所はここから efsumi2014_donmaico20140712 働く場所はここから efsumi2014_donmaico
20140712 働く場所はここから efsumi2014_donmaicoMaiko Nakajima
 
Journalistisk workshop
Journalistisk workshopJournalistisk workshop
Journalistisk workshopKasperWood
 
育儿塘 app design for ipad
育儿塘 app design for ipad育儿塘 app design for ipad
育儿塘 app design for ipadGinger Yu
 
Othello background power point
Othello background power pointOthello background power point
Othello background power pointjassch
 
Android Design Pattern-CH Part i
Android Design Pattern-CH Part iAndroid Design Pattern-CH Part i
Android Design Pattern-CH Part iGinger Yu
 
Approach to Investment
Approach to InvestmentApproach to Investment
Approach to InvestmentPaulMcDonnell
 
Radiological measurements
Radiological measurementsRadiological measurements
Radiological measurementsnoorulain89
 
Makalah pai-akhlak
Makalah pai-akhlakMakalah pai-akhlak
Makalah pai-akhlakSaepul Thea
 
Metal semiconductor contact
Metal semiconductor contactMetal semiconductor contact
Metal semiconductor contactAnchit Biswas
 

En vedette (19)

Calificaciones
CalificacionesCalificaciones
Calificaciones
 
Android Design Pattern-CH Part ii
Android Design Pattern-CH Part iiAndroid Design Pattern-CH Part ii
Android Design Pattern-CH Part ii
 
Corprate Brochure
Corprate BrochureCorprate Brochure
Corprate Brochure
 
01 arosa'01
01 arosa'0101 arosa'01
01 arosa'01
 
Calificaciones
CalificacionesCalificaciones
Calificaciones
 
Android design pattern
Android design patternAndroid design pattern
Android design pattern
 
Othello background power point notes sheet
Othello background power point notes sheetOthello background power point notes sheet
Othello background power point notes sheet
 
Android Design Pattern-CH Part iii
Android Design Pattern-CH Part iiiAndroid Design Pattern-CH Part iii
Android Design Pattern-CH Part iii
 
20140712 働く場所はここから efsumi2014_donmaico
20140712 働く場所はここから efsumi2014_donmaico20140712 働く場所はここから efsumi2014_donmaico
20140712 働く場所はここから efsumi2014_donmaico
 
Journalistisk workshop
Journalistisk workshopJournalistisk workshop
Journalistisk workshop
 
育儿塘 app design for ipad
育儿塘 app design for ipad育儿塘 app design for ipad
育儿塘 app design for ipad
 
130531 j master
130531 j master130531 j master
130531 j master
 
Othello background power point
Othello background power pointOthello background power point
Othello background power point
 
Android Design Pattern-CH Part i
Android Design Pattern-CH Part iAndroid Design Pattern-CH Part i
Android Design Pattern-CH Part i
 
Approach to Investment
Approach to InvestmentApproach to Investment
Approach to Investment
 
Radiological measurements
Radiological measurementsRadiological measurements
Radiological measurements
 
Makalah pai-akhlak
Makalah pai-akhlakMakalah pai-akhlak
Makalah pai-akhlak
 
Fiqih kelas 6
Fiqih kelas 6Fiqih kelas 6
Fiqih kelas 6
 
Metal semiconductor contact
Metal semiconductor contactMetal semiconductor contact
Metal semiconductor contact
 

Similaire à Boosting Healthy Lifespans Through Prevention

Health co morbidity effects on injury compensation claims in NZ, and evidence...
Health co morbidity effects on injury compensation claims in NZ, and evidence...Health co morbidity effects on injury compensation claims in NZ, and evidence...
Health co morbidity effects on injury compensation claims in NZ, and evidence...John Wren
 
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
 
G7 high-level side event in Niigata
G7 high-level side event in NiigataG7 high-level side event in Niigata
G7 high-level side event in NiigataILC- UK
 
Neil Fraser
Neil FraserNeil Fraser
Neil Fraserichil
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Camp Days
 
| Jose Poulose | Preventive health services by Dr jose poulose |
| Jose Poulose | Preventive health services by Dr jose poulose || Jose Poulose | Preventive health services by Dr jose poulose |
| Jose Poulose | Preventive health services by Dr jose poulose |Dr. Jose Poulose
 
WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)Taketo Tanaka
 
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015Carole Bruckler, PhD
 
Npsf webcast psaw_live_slides_v1
Npsf webcast psaw_live_slides_v1Npsf webcast psaw_live_slides_v1
Npsf webcast psaw_live_slides_v1Jordan Rivera
 
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...ICF
 
Macro-trend PPW draft
Macro-trend PPW draftMacro-trend PPW draft
Macro-trend PPW draftEshetu Dan
 
Reshaping Hong Kong's Healthcare
Reshaping Hong Kong's HealthcareReshaping Hong Kong's Healthcare
Reshaping Hong Kong's HealthcareVictoria Tseng
 
Macro-trend PPW draft
Macro-trend PPW draftMacro-trend PPW draft
Macro-trend PPW draftEshetu Dan
 
Balancing demand, quality and efficiency in nigerian health care delivery system
Balancing demand, quality and efficiency in nigerian health care delivery systemBalancing demand, quality and efficiency in nigerian health care delivery system
Balancing demand, quality and efficiency in nigerian health care delivery systemAlexander Decker
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayVITAS Healthcare
 

Similaire à Boosting Healthy Lifespans Through Prevention (20)

Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
Medicina Digital e as Novas Fronteiras: da assistencia `a pesquisa
 
Health co morbidity effects on injury compensation claims in NZ, and evidence...
Health co morbidity effects on injury compensation claims in NZ, and evidence...Health co morbidity effects on injury compensation claims in NZ, and evidence...
Health co morbidity effects on injury compensation claims in NZ, and evidence...
 
Mr. Patrick Marie Herbet
Mr. Patrick Marie HerbetMr. Patrick Marie Herbet
Mr. Patrick Marie Herbet
 
The Shifting Landscape of Healthcare in Asia-Pacific
The Shifting Landscape of Healthcare in Asia-PacificThe Shifting Landscape of Healthcare in Asia-Pacific
The Shifting Landscape of Healthcare in Asia-Pacific
 
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...
 
A Workshop Looking At The Evidence on Workplace Health Wellness Programmes:
A Workshop Looking At The Evidence on Workplace Health Wellness Programmes:A Workshop Looking At The Evidence on Workplace Health Wellness Programmes:
A Workshop Looking At The Evidence on Workplace Health Wellness Programmes:
 
G7 high-level side event in Niigata
G7 high-level side event in NiigataG7 high-level side event in Niigata
G7 high-level side event in Niigata
 
Neil Fraser
Neil FraserNeil Fraser
Neil Fraser
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
 
| Jose Poulose | Preventive health services by Dr jose poulose |
| Jose Poulose | Preventive health services by Dr jose poulose || Jose Poulose | Preventive health services by Dr jose poulose |
| Jose Poulose | Preventive health services by Dr jose poulose |
 
HIV-sensitive social protection in Asia - November 2012
HIV-sensitive social protection in Asia - November 2012HIV-sensitive social protection in Asia - November 2012
HIV-sensitive social protection in Asia - November 2012
 
WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)
 
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015
Deallus-Consulting-JPMA-ASEAN-Seminar-March-2015
 
Npsf webcast psaw_live_slides_v1
Npsf webcast psaw_live_slides_v1Npsf webcast psaw_live_slides_v1
Npsf webcast psaw_live_slides_v1
 
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...
What is the Evidence and Return on Investment (ROI) of Obesity Prevention and...
 
Macro-trend PPW draft
Macro-trend PPW draftMacro-trend PPW draft
Macro-trend PPW draft
 
Reshaping Hong Kong's Healthcare
Reshaping Hong Kong's HealthcareReshaping Hong Kong's Healthcare
Reshaping Hong Kong's Healthcare
 
Macro-trend PPW draft
Macro-trend PPW draftMacro-trend PPW draft
Macro-trend PPW draft
 
Balancing demand, quality and efficiency in nigerian health care delivery system
Balancing demand, quality and efficiency in nigerian health care delivery systemBalancing demand, quality and efficiency in nigerian health care delivery system
Balancing demand, quality and efficiency in nigerian health care delivery system
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of Stay
 

Dernier

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 

Dernier (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 

Boosting Healthy Lifespans Through Prevention

  • 1. Presenting the ACCJ-EBC Health Policy White Paper 2013 May 31, 2013 Lengthening Healthy Lifespans to Boost Economic Growth
  • 3. About American Chamber of Commerce in Japan Established 1948 Committee structure drives Chamber activities around three pillars: • Information • Networking • Advocacy Approximately 2700 members representing 1000 companies Over 500 events per year in three chapters across Japan Approximately half of members are Japanese
  • 4. Achieving Growth Together Japan Economic Growth ACCJ Membership Growth ACCJ Member Personal Growth ACCJ’s Three Primary Areas for Growth 成 長 共 就
  • 5. Preventive Health Investment Drives Growth Japan’s aging is rapidly increasing healthcare utilization Worker productivity is key to sustain healthcare and grow the economy • Disease costs Japanese economy 3.3 trillion yen per year in lost productivity (2011 ACCJ National Survey) A shift to prevention and early detection is necessary to:  Increase healthy life years  Lower economic burden of disease  Support economic growth
  • 6. • Gaps between average life expectancy and healthy life expectancy represent an unhealthy period with daily life constraints • There may be medical and nursing expenses during this period 70.42 79.64 60 73.62 86.39 65 70 75 80 85 90 Year 9.22 years 12.77 years Average life expectancy Healthy life expectancy (No daily life constraints) Gap between average and healthy life expectancy Male Female Source: Healthy Japan 21 (Second Version) Importance of Healthier Life Expectancy
  • 7. ACCJ-EBC Health Policy White Paper 2013 Promoting economic growth in Japan through policies to lengthen healthy lifespans and reduce economic burden of preventable, detectable and treatable diseases 36 healthcare topics Over 150 policy recommendations
  • 9. About European Business Council in Japan Trade policy arm of 17 European National Chambers of Commerce and Business Associations in Japan Working to improve the trade and investment environment for European companies in Japan since 1972 Approximately 3000 local European corporate and individual members Approximately 400 companies participating directly
  • 10. Rise in Non-Communicable Diseases Is a Leading Threat to Global Economic Growth WHO report: each 10% rise in non- communicable diseases is linked to a 0.5% dip in annual economic growth; recent global rise in NCDs is “economically unsustainable.” The World Economic Forum forecasts that NCDs will cost the global economy $47 trillion over the next 20 years. • Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.” Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010,” WHO, http://www.who.int/nmh/publications/ncd_report2010/en/ • Working Towards Wellness: The Business Rationale. World Economic Forum, Geneva, 2008. Bloom, et al., 2011.
  • 11. NCDs account for about 30% of national healthcare expenditure and about 60% of total deaths Healthcare Expenditure Cancers 11.1% Hypertension-related diseases 7.1% Cerebral vascular diseases 6.3% Diabetes 4.4% Cardiovascular diseases 2.9% Others 68.3% Cancers 29.5% Cardiovascular diseases 15.8% Cerebral vascular diseases 10.3% Diabetes 1.2% Hypertension-related diseases 0.6% Others 42.6% Mortality Source: Healthy Japan 21 (Part 2) Non-Communicable Diseases in Japan are Costly, Deadly and Often Preventable
  • 12. “Every 1 year increase in life expectancy is linked to a 4.3% increase in global GDP.” Sources: Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.” Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010, WHO, http://www.who.int/nmh/publications/ncd_report2010/en/. Spending to Promote Health is a Very Good Economic Investment
  • 13. William Bishop Chair, ACCJ Healthcare Committee
  • 14. 2010 2010 Health Policy White Paper 2010
  • 15. 2011 Health Policy White Paper 2011 Scope: • 27 Topic Sections • 124 Recommendations Results: • 46 of 124 recommendations (roughly 37%) fulfilled “in part" or in whole Areas of Progress: • Continued government funding of national cancer screening • Substantial increased funding to enhance infection prevention and control at hospitals in Japan (four fold for hospitals with >300 beds). • Expanded use of IVD Rapid Diagnostics • Diabetes Management • Osteoporosis Prevention • Chronic Pain Research Funding • Vaccination Policy • Hepatitis Screening & Awareness Initiatives
  • 16. Source: Inhibitex Nearly 6 million HAIs annually in U.S., Europe and Japan 1.7 million cases and 99,000 deaths annually in the U.S. In some developing countries, more than 25% of patients admitted to hospitals acquire HAIs Hundreds of millions of patients impacted worldwide each year Healthcare Associated Infections (HAIs): A Global Healthcare Issue Millions of Infections 8 6 4 2 0 2002 2005 2009 2010 2015 5.6 5.9 6.3 6.4 6.9 Japan Europe U.S.
  • 17. Q. How important do you think it is for the government to have a national program to reduce the risk of infections associated with hospitals, clinics or other healthcare facilities? 75.7% of General Public in Japan Think it is Important to Have a National Program to Reduce the Risk of HAIs (80% for population over 65) ■ Important ■ Slightly important ■ Neither nor ■ Do not know ■ Not very important ■ Not important 52.4 48.9 48.5 43.0 37.3 31.4 29.4 40.8 40.2 40.5 27.4 30.6 32.9 36.2 36.4 39.2 38.1 35.9 34.4 35.2 7.7 12.9 11.2 12.1 15.9 17.6 18.6 14.4 14.2 14.3 10.6 5.6 5.6 5.9 7.4 7.9 7.4 6.3 7.2 6.8 1.9 1.4 1.2 2.1 1.8 2.5 6.6 2.0 2.2 2.1 0% 20% 40% 60% 80% 100% 80+ yrs old (n=208) 70-79 yrs old (n=790) 60-69 yrs old (n=882) 50-59 yrs old (n=779) 40-49 yrs old (n=800) 30-39 yrs old (n=863) 20-29 yrs old (n=678) Female (n=2599) Male (n=2401) Overall (n=5000) Is Important 75.7% 74.6% 76.6% 67.4% 70.6% 73.6% 79.2% 81.4% 79.5% 79.8% Not Important 3.3% 3.9% 2.6% 6.6% 3.9% 3.2% 2.9% 1.8% 2.0% 1.9% Survey on Prevention, Early Detection and the Economic Burden of Disease in Japan (2011) by The American Chamber of Commerce in Japan. Internet survey conducted October 31 – November 2, 2011. 5,000 respondents from Rakuten Research’s registry that represent the Japanese population.
  • 18. 2013 2013 ACCJ-EBC Health Policy White Paper Scope: • 36 Topic Sections • 156 Recommendations Chapters: 1. General Health Themes 2. Non-communicable Disease (NCD) Topics 3. Women’s Health Topics 4. Key Infectious Disease Topics 5. Importance of Enhanced Safety & Infection Control 6. Special Focus Needed on Healthcare Worker Safety
  • 19. Danny Risberg Chair, EBC Medical Equipment Committee
  • 20. Deaths Caused by and Patients of Cerebrovascular Diseases 100 125 150 175 200 0 250 500 750 1,000 1,250 1,500 1,750 2,000 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 # of death (1,000 ppl) # of Patients (1,000 ppl) # of Patients # of Death Source: Ministry of Health, Labor, and Welfare (Trend of Medical Institution)
  • 21. 76.8% 13.3% 2.4% 7.5% Cerebral hemorrhage Cerebral infarction Subarachnoid hemorrhage Others 1960 1999 Source: Ministry of Health, Labor, and Welfare (Vital Statistics) Deaths Caused By Cerebrovascular Diseases 23.0% 62.7% 10.8% 3.5%
  • 22. Vessel Wall Imaging Done by MRI
  • 23. Sleep Apnea Syndrome (over 3 million patients) 13% have diabetes (390,000 patients) 21% have cardiovascular diseases (630,000 patients) 41% no complication (1,230,000 patients) 51% have hypertension (1,530,000 patients) Undergoing Treatment (250,000 patients) Increase Sleep Apnea Syndrome Screening
  • 24. Eriko Asai Chair, ACCJ Health IT Subcommittee
  • 25. 71.5% of Japanese Back Introduction of Electronic Health Records at Hospitals, Clinics Support/Agree Slightly Support/Agree Neither Don’t know Slightly Oppose/Disagree Oppose/Disagree 50.0 48.2 52.4 42.2 40.3 35.9 36.1 37.9 48.7 43.1 23.6 28.0 24.3 28.4 28.3 33.4 29.8 31.6 25.0 28.4 14.4 16.1 17.1 22.2 22.8 20.4 20.8 21.8 17.2 19.6 10.1 5.1 4.4 5.4 5.9 6.6 8.3 5.9 6.2 6.0 0.5 1.9 1.5 1.2 2.3 2.5 2.9 2.2 1.7 2.0 0% 20% 40% 60% 80% 100% 80+ yrs old (n=208) 70-79 yrs old (n=790) 60-69 yrs old (n=882) 50-59 yrs old (n=779) 40-49 yrs old (n=800) 30-39 yrs old (n=863) 20-29 yrs old (n=678) Female (n=2599) Male (n=2401) Overall (n=5000) 71.5% 73.7% 69.4% 65.9% 69.3% 68.5% 70.6% 76.6% 76.2% 73.6% Support Oppose 2.9% 2.9% 2.9% 5.0% 3.7% 2.9% 1.8% 1.8% 2.7% 1.9% Q: Do you support or oppose the introduction of electronic health records at hospitals and clinics in Japan? Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov, 2011.
  • 26. Supporters of EHR System Expect More Efficiency, Safer Medical Service (n=3,574) Q: Why do you support the introduction of an electronic health record (EHR) system at hospitals and clinics in Japan? (multiple answers) Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov. 2011.
  • 27. 24.3% 70% 75% Breast Cancer Screening Rates Lower Than OECD Average Sources: http://www.mhlw.go.jp/stf/houdou/2r9852000001igt0.html, http://www.oecdto Mammography screening rates in Japan rising, but still low 62.2% Free National Breast Cancer Screening Launched in 2009 Scope: Women aged 40, 45, 50, 55, and 60 Funding: 100% by central government Japan Goal: 50% screening rate by 2011 Recruitment: Send coupons to eligible women
  • 28.  Has a 28% survival rate over five years  Costs up to ¥4 million to treat  Has 96% survival rate over five years  Costs about ¥760,000 to treat Breast cancer diagnosed in early stages Breast cancer diagnosed after it has metastasized Breast Cancer Screening: Cost Effective and Saves Lives  Sense no need, as have no lump  Lack of opportunity  High fees Top three reasons women do not have a mammogram
  • 30. Two Thirds Support a Mandated Indoor Worksite Smoking Ban Question: What would you think if the national or local governments legally required a complete smoking ban in all indoor workplaces and public spaces, including restaurants, bars and taxis, to protect the health of non-smoking workers? Source: Japan national survey on passive smoking in the workplace for 8,000 indoor workers by Johnson & Johnson K.K. Consumer Company, released on July 19th, 2012
  • 31. 70% of Indoor Workers: Legal Smoking Ban Would Not Negatively Impact Business Question: How would your business be impacted if national or local governments legally required a total smoking ban in all indoor workplaces and public spaces, including restaurants, bars and taxis, to protect the health of non-smoking workers? Source: Japan national survey on passive smoking in the workplace of 8,000 indoor workers by Johnson & Johnson K.K. Consumer Company, July 2012
  • 32. 322011 MHLW’ National Survey on Getting-tested status of Hepatitis Screening (Interviewed 74,000 Japanese people aged 20 thru 79 years old) Only Half of Adults in Japan Have Been Screened for Hepatitis Japanese government has provided free hepatitis screening since 2002 as the time of regular health checkup services by municipal governments. Free screening was first provided at public health centers and later also available at hospitals and clinics. Need to further increase screening rate, especially for people aged 40 and over. HCV Screening Rate: Est. 48%HCB Screening Rate: Est. 57% Tested at time of surgery, pregn ancy, blood donation 40% No, I have not or do not know 42% Yes, I have been tested (self- reported) 18% Yes, I have been tested (self- reported) 18% No, I have not or do not know 52% Tested at time of surgery, pregn ancy, blood donation 30%
  • 33. Large Company Employers Small and Medium Company Employers Self-Employed and Others Type of health insurance in which employee enrolls Managed by health insurance societies or associations Managed by members of Japan Health Insurance Association Managed by municipalities, National Health Insurance associations Provision of health checkups based on Industrial Safety & Health Act Yes, required (Employers are required to provide) Not required Provision of special health checkups based on Law for the Welfare of the Elderly (aged 40 or over) Yes, provision is required (Insurance provider is required to provide) Rate at which hepatitis screening is part of special health checkup Approx. 50% Approx. 95% Individuals must pay ¥595 as co-payment and apply separately for this optional hepatitis virus testing. Approx. 80% Free but implementation varies by town, city. Screening notices usually go to specific age groups. Source: MHLW, “Status of implementation of Specific Medical Checkups/Health Guidance in FY2010” http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info03_h22.html Provision of Hepatitis Screening Varies Widely According to Type of Insurer
  • 34. 2013 ACCJ-EBC Health Policy White Paper • Paradigm shift from treatment to prevention  Focusing on prevention, screening, early detection and early treatment of disease • Efficient allocation of healthcare resources  Enhancing productivity and reducing waste • Evidence-based global best practices  Recommendations with potential to yield significant positive impact • Alignment with government growth policy goals  Recommendations with potential to boost economic growth Disease prevention • Cost effective interventions • Better patient outcomes and quality of life • Enhanced labor productivity
  • 35. Presenting the ACCJ-EBC Health Policy White Paper 2013 May 31, 2013 Lengthening Healthy Lifespans to Boost Economic Growth

Notes de l'éditeur

  1. Established in 1948Approximately 2700 members representing 1000 companiesOver 500 events per year in three chapters across Japan:Tokyo, Chubu (Nagoya), Kansai (Osaka)Approximately half of the members are JapaneseCommittee structure drives Chamber activities around three pillarsInformationNetworkingAdvocacy
  2. In 2013, ACCJ is addressing three primary areas for growth:Japan’s economic growthACCJ membership growthACCJ member personal growth
  3. Japan is an aging society with a declining population.High productivity level of the labor force is a primary source of Japan’s international competitiveness and economic growth.ACCJ’s 2011 national survey shows that disease costs Japanese economy 3.3 trillion yen per year in lost productivity, and higher level of absenteeism and disability. This figure does not include economic loss due to medical expenditure.Investment in health now focuses on lowering the economic burden and supporting economic growth, by reducing the burden of preventable, detectable and treatable disease through prevention, screening, early detection and the early treatment of disease.Such investment will improve patient outcomes, improve quality of life, increase worker productivity and ultimately support economic growth.
  4. There is a significantgap between Japan’s average life expectancy and its healthy life expectancy.People are living longer but many of those life years are spent ill or in need of treatment or care.It is critical to raise the healthy life expectancy to the level of average life expectancy, because:It enhances people’s livesIt increases labor productivity It shifts healthcare expenditure from treatment to prevention, which is an investment in growth
  5. ACCJ and EBC are pleased to offer this white paper in an effort to support economic growth in Japan through policies that lengthen healthy lifespans and reduce the economic burden of preventable, detectable and treatable diseases.Recommendations are aimed at putting a greater emphasis on prevention and early detection and are based on global evidence and best practices.The ACCJ and EBC agreed to work together to issue our first joint Health Policy White Paper, to enhance the scope and quality of our recommendations and to align our recommendations with current government growth policy goalsWe believe the 2013 ACCJ-EBC Health Policy White Paper represents our most comprehensive set of healthcare policy recommendations to date.Now I will turn to Duco Delgorge, our valued partner in this very exciting endeavor.
  6. The European Business Council in Japan (EBC) is the trade policy arm of 17 European National Chambers of Commerce and Business Associations in Japan and has been working to improve the trade and investment environment for European companies in Japan since 1972. The EBC currently works for around 3,000 local European corporate and individual members with some 400 companies participating directly in the EBC’s 30 sector-based committees.The common bond among the members of the EBC and ACCJ is the desire to improve the quality of healthcare in Japan and the wellbeing of the Japanese people.
  7. Globally and in Japan, more people are living longer.However, many of those years are increasingly spent under care for chronic – often preventable --disease.A shift from a purely disease treatment paradigm to a prevention paradigm that focuses on prevention, screening, early detection and the early treatment of disease holds the promise of not only preventing disease and enhancing quality of life and worker productivity, but in yielding cost effective interventions and better patient outcomes.
  8. Many forms of chronic disease can be prevented or detected early, but health policies in Japan have traditionally focused on the treatment of disease after it occurs or grows critical, which can result in higher treatment costs.Here, you can see the significant proportion of healthcare expenditure and deaths that are due to non-communicable diseasesThese are conditions that, if prevented or detected earlier, would pose a much lighter burden on Japanese healthcare system, which is surely a benefit to society.
  9. Finally, not only does preventative health and early detection of disease improve patient outcomes and create efficiencies in the healthcare system, it is an investment in the overall economic output and competitiveness of Japan.A more efficient allocation of healthcare resources that provides better patient outcomes boosts the economy in two important ways: it enhances labor productivity and reduces waste.   Our goal is to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact.
  10. Background Since 2008, the ACCJ Healthcare Committee has released a series of Viewpoints advocating a shift from a purely disease treatment paradigm to a prevention paradigm that focuses on prevention, screening, early detection and the early treatment of disease which holds the promised of not only preventing disease and enhancing quality of life and worker productivity, but in yielding cost effective interventions and better patient outcomes.
  11. Slide #1In 2010, the first Health Policy White Paper was issued as a companion document covering healthcare reform recommendations for the ACCJ white paper “Charting a new Course for Growth – Recommendations for Japan’s Leaders” issued by the ACCJ Growth Strategy Taskforce, which highlighted the initiatives that will enable Japan to achieve the goal of enhancing economic growth.
  12. Slide#2In 2011, the ACCJ Health Policy White Paper was greatly expanded from 12 topic sections to 27 topic sections under the title “Investing in Health as a Competitive Advantage- Proposals to Reduce the Burden of Disease by Promoting Prevention and Early Detection”. Again, the goal was to support Japan’s economic growth strategy. It has been our goal to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact. That being said, to gage the effectiveness of the 2011 white paper recommendations, a review was conducted after the implementation of reforms on April 1, 2012. In brief, forty-six (or roughly 37%) of the one hundred twenty-four (124) recommendations in the 2011 Health Policy White Paper were found to have been fulfilled "In Part" or in whole.  Notable progress was made in: Expansion of IVD Rapid Diagnostics; Diabetes Management; Osteoporosis Prevention; Chronic Pain Research Funding; Vaccination Policy and Hepatitis Screening and Awareness Initiatives. The most significant progress was seen in the continued government funding of national cancer screening initiatives and in the substantial increase in government funding to enhance infection prevention and control at hospitals in Japan (four fold for hospitals with >300 beds).
  13. Slide #5To update and further enhance the quality of the Health Policy White Paper and to align our recommendations with current government growth policy goals, the ACCJ and EBC agreed to work together to issue our first joint health policy white paper, “ACCJ–EBC Health Policy White Paper 2013 - Lengthening Healthy Lifespans to Boost Economic Growth”. Several new or expanded topic sections were added to the 2013 white paper including new topics sections for mental health, noncommunicable diseases, infection prevention & control and healthcare worker safety. The 2013 white paper is divided into Six Chapters, covering 36 topic sections and over 150 policy recommendations.General Health Themes Noncommunicable Disease (NCD) TopicsWomen’s Health TopicsKey Infectious Disease TopicsImportance of Enhanced Safety & Infection ControlSpecial Focus Needed on Healthcare Worker Safety Again, our goal is to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact. Thanks to our collaboration with our European colleagues, we believe the 2013 ACCJ-EBC Health Policy White Paper represents our most comprehensive set of healthcare policy recommendations to date.